Induction of natural killer activity by Xanthenone analogues of flavone acetic acid: Relation with antitumour activity

Plowman, 1986, Flavone aetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice, Cancer Treat Rep, 70, 631

O'Dwyer, 1987, Flavone acetic acid (LM 975, NSC 347512), a novel antitumor agent, Cancer Chemother Pharmacol, 19, 6, 10.1007/BF00296246

Kerr, 1989, Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal cancer, Br J Cancer, 60, 104, 10.1038/bjc.1989.230

Finlay, 1988, Effect of flavone acetic acid (NSC 347512) on Lewis lung carcinoma, evidence for an indirect effect, J Natl Cancer Inst, 80, 241, 10.1093/jnci/80.4.241

Ching, 1987, Induction of natural killer cell activity by the antitumour compound flavone acetic acid (NSC 347512), Eur J Cancer Clin Ocol, 23, 1047, 10.1016/0277-5379(87)90357-9

Wiltrout, 1988, Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer, J Immunol, 140, 3261, 10.4049/jimmunol.140.9.3261

Urba, 1988, Enhancement of natural killer activity in human peripheral blood by flavone acetic acid, J Natl Cancer Inst, 80, 521, 10.1093/jnci/80.7.521

Hornung, 1988, Immunomodulation of natural killer cell activity by flavone acetic acid, occurrence via induction of interferon α/β, J Natl Cancer Inst, 80, 1226, 10.1093/jnci/80.15.1226

Hornung, 1988, Augmentation of natural killer (NK) activity, induction of interferon and development of tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid (FAA) and interleukin 2, J Immunol, 141, 3671, 10.4049/jimmunol.141.10.3671

Mace, 1990, Induction of cytokine expression in vivo by flavone acetic acid: strict dose dependency and correlation with therapeutic efficacy against murine renal cancer, Cancer Res, 50, 1742

Rewcastle, 1988, Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo, J Med Chem, 32, 793, 10.1021/jm00124a012

Atwell, 1989, Potential antitumor agents. 60. Relationships between structure and in vivo colon 38 activity for 5-substituted xanthenone-4-acetic acids, J Med Chem, 33, 1375, 10.1021/jm00167a015

Baguley, 1989, Comparison of the effects of flavone acetic acid, fostriecin and homoharringtonine and tumour necrosis factor α on colon 38 tumors in mice, Eur J Cancer Clin Oncol, 25, 263, 10.1016/0277-5379(89)90018-7

Bibby, 1989, Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy, J Natl Cancer Inst, 81, 216, 10.1093/jnci/81.3.216

Zwi, 1989, Blood flow failure as a major determinant in the antitumor action of flavone acetic acid (NSC 347512), J Natl Cancer Inst, 81, 1005, 10.1093/jnci/81.13.1005

Ching, 1989, Hyporesponsiveness of macrophages from C3HHeJ (endotoxin-resistant) mice to the antitumour drug flavone acetic acid (NCS 347512), Eur J Cancer Clin Oncol, 25, 1513, 10.1016/0277-5379(89)90116-8

Thomsen, 1990, Evidence for the production of nitric oxide by activated macrophages treated with the antitumour agents flavone-8-acetic acid and xanthenone-4-acetic acid, Cancer Res, 50, 6966

Schroyens, 1987, In vitro chemosensitivity testing of flavone acetic acid (LM 975; NSC 347512) and its diethylaminoethyl ester derivative (LM 985; NSC 293015), Eur J Cancer Clin Oncol, 23, 1135, 10.1016/0277-5379(87)90146-5